A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.

Saved in:
Bibliographic Details
Title: A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.
Authors: Sehgal R; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Lembersky BC, Rajasenan KK, Crandall TL, Balaban EP, Pinkerton RA, Kane P, Schmotzer A, Zeh H, Potter DM, Ramanathan RK
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2011 Jun; Vol. 10 (2), pp. 117-20. Date of Electronic Publication: 2011 Apr 28.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0674
DOI:10.1016/j.clcc.2011.03.008